Description:

Study Drug Therapy Form for Protocol #010--PR1003 Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF9311DF-A3A4-2D7C-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF9311DF-A3A4-2D7C-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 8/9/14
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

AIDS-Related Lymphoma NCT00310128 Treatment - Study Drug Therapy Form for Protocol #010--PR1003 - 2399688v3.0

No Instruction available.

  1. StudyEvent: Study Drug Therapy Form for Protocol #010--PR1003
    1. No Instruction available.
General info
cm
kg
m2
Initial Prescribed Dose Of Study Drug
Enter Total Dose Of Study Drug Received This Cycle And Dose Modification Codes
Dose Modification